Drawing for KRINGLE PHARMA, INC.

USPTO serial 77113149

KRINGLE PHARMA, INC.

Reviewed by CopyMark Law Group

Reg. 3266636Status 710
Filing date
Status date
Registration date
Jul 17, 2007
Examiner
TIERNEY, MARGERY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KRINGLE PHARMA, INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amy E. Schmid

Ray Thomas, Jr. Wenderoth, Lind & Ponack, L.L.P.1030 15th Street N.W.Suite 400 EastWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer and sanitary preparations for medical use; central nervous system stimulants; hair growth stimulant; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; pharmaceutical preparations acting on the peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics; antispasmodics; diaphoretics; pharmaceutical preparations acting on the sensory organs; ophthalmic preparations; agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; treatment for eye infection, macular degeneration, retinopathy, rhinitis, sinusitis; pharmaceutical antiallergic preparations; antihistaminics; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical preparations acting on respiratory organs; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs; gastrointestinal cleaning agents; clysters; evacuants (purgatives); stomachics and digestives; pharmaceutical preparations for oral use, for oral inflammation; emetics; pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, alveoloclasia; antacids; antiemetics; castor oil for medical purposes; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations acting on uro-genital and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives; medicated skin care preparations; pharmaceutical preparations for purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents; anti-inflammatory agents; analgesics; anti-itchings; talcum powder; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements; chondroitin preparations; protein and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics; pharmaceutical preparations affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of habitual intoxication; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating heatstroke; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, immunosuppresants; chlorine-detoxication preparations; arsenic-detoxication preparations; benzol-detoxication preparations; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; salkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes; antitoxic sera; antitoxins; mixed biological preparations for medical purposes; preparations for biological tests for medical purposes; toxoids; vaccines; preparations for destroying parasites; anthelmintics; odor neutralizing preparations for use on drugs; pharmaceutical excipients; diagnostic preparations for medical use; X-ray contrast agents; diagnostic reagents for medical use; diagnostic media for bacteriological cultures for medical use; radio isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides, namely, weedkillers; insect-repellents; antisepticsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 21, 2014C8..CANCELLED SEC. 8 (6-YR)—
Jan 13, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2007R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jun 13, 2007CNEAEXAMINER'S AMENDMENT MAILED—
Jun 12, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 12, 2007CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Jun 12, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Jun 12, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 9, 2007DOCKASSIGNED TO EXAMINER—
May 3, 2007AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
May 3, 2007ALIEASSIGNED TO LIE—
Apr 5, 2007PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 27, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance